Julián Torre‐Cisneros
Instituto de Salud Carlos III(ES)Instituto Maimónides de Investigación Biomédica de Córdoba(ES)Centro de Investigación Biomédica en Red(ES)Hospital Universitario Reina Sofía(ES)Jena University Hospital(DE)Instituto de Investigación de Enfermedades Raras(ES)Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI)(DE)University of Córdoba(ES)Friedrich Schiller University Jena(DE)
Publications by Year
Research Areas
Cytomegalovirus and herpesvirus research, Antibiotic Resistance in Bacteria, Herpesvirus Infections and Treatments, Pneumocystis jirovecii pneumonia detection and treatment, Antibiotics Pharmacokinetics and Efficacy
Most-Cited Works
- → Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial(2020)746 cited
- → Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections(2003)674 cited
- → HIV coinfection shortens the survival of patients with hepatitis C virus‐related decompensated cirrhosis†(2005)279 cited
- → Tuberculosis in Solid‐Organ Transplant Recipients: Consensus Statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology(2009)255 cited
- → Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant Organisms(2016)251 cited
- → ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers